References and Notes
1a
Ryu Y.
Schultz PG.
Nature
Methods
2006,
3:
263
1b
Wang Q.
Parrish AR.
Wang L.
Chem.
Biol.
2009,
16:
323
2
Connor RE.
Piatkov K.
Varshavsky A.
Tirrell DA.
ChemBioChem
2008,
9:
366
3
Van Hest JCM.
Kiick KL.
Tirrell DA.
J. Am. Chem. Soc.
2000,
122:
1282
4a
Kiick KL.
Saxon E.
Tirrell DA.
Bertozzi CR.
Proc. Natl Acad. Sci. U.S.A.
2002,
99:
19
4b
Link AJ.
Tirrell DA.
J.
Am. Chem. Soc.
2003,
125:
11164
5
Datta D.
Wang P.
Carrico IS.
Mayo SL.
Tirrell DA.
J. Am. Chem. Soc.
2002,
124:
5652
6a
Best MD.
Biochemistry
2009,
48:
6571
6b
Baskin
JM.
Bertozzi CR.
QSAR
Comb. Sci.
2007,
26:
1211
7a
Oh K.-I.
Lee J.-H.
Joo C.
Han H.
Cho M.
J.
Phys. Chem. B
2008,
112:
10352
7b
Ye S.
Huber T.
Vogel R.
Sakmar TP.
Nature Chem. Biol.
2009,
5:
397
8a
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless KB.
Angew. Chem. Int. Ed.
2002,
41:
2596
8b
Kolb
HC.
Finn MG.
Sharpless KB.
Angew. Chem. Int. Ed.
2001,
40:
2004
8c
Meldal M.
Tornoe CW.
Chem. Rev.
2008,
108:
2952
9a
Codelli JA.
Baskin JM.
Agard NJ.
Bertozzi CR.
J. Am. Chem. Soc.
2008,
130:
11486
9b
Baskin JM.
Prescher JA.
Laughlin ST.
Agard NJ.
Chang PV.
Miller IA.
Lo A.
Codelli JA.
Bertozzi CR.
Proc.
Natl Acad. Sci. U.S.A.
2007,
104:
16793
9c
Sletten EM.
Bertozzi CR.
Org.
Lett.
2008,
10:
3097
10
Agard NJ.
Baskin JM.
Prescher JA.
Lo A.
Bertozzi CR.
ACS Chem. Biol.
2006,
1:
644
11
Link AJ.
Vink MKS.
Tirrell DA.
J. Am. Chem. Soc.
2004,
126:
10598
12a
Panda G.
Rao NV.
Synlett
2004,
714
12b
Maier
THP.
Nature Biotechnol.
2003,
21:
422
12c
Wie L.
Lubell WD.
Can. J. Chem.
2001,
79:
94
12d
Davoli P.
Forni A.
Moretti I.
Prati F.
Tetrahedron: Asymmetry
1995,
6:
2011
12e
Arnold LD.
May RG.
Vederas JC.
J. Am. Chem. Soc.
1988,
110:
2237
12f
Mangold JB.
Lavelle JM.
Chem.-Biol.
Interact.
1986,
60:
183
12g
Owais WM.
Ronald RC.
Kleinhofs A.
Nilan RA.
Mut.
Res. Lett.
1986,
175:
121
12h
Golding BT.
Howes C.
J. Chem. Res.
1984,
1
13
Link AJ.
Vink MKS.
Tirrell DA.
Nature Protoc.
2007,
2:
1884
14
Link AJ.
Vink MKS.
Tirrell DA.
Nature Protoc.
2007,
2:
1879
15
Mangold JB.
Mischke MR.
Lavelle JM.
Mutat. Res.
1989,
216:
27
16
Oppolzer W.
Moretti R.
Zhou C.
Helv.
Chim. Acta
1994,
77:
2363
17
McLaughlin M.
Mohreb RM.
Rapoport H.
J.
Org. Chem.
2003,
68:
50
18
Broadrup RL.
Wang B.
Malachowski WP.
Tetrahedron
2005,
61:
10277
19 To a solution of alcohol 5 (269 mg, 0.87 mmol,
1.0 equiv)
in CH2Cl2 (5 mL)
at 0 ˚C, was added Et3N (288 µL, 2.09 mmol,
2.4 equiv) followed by dropwise addition of methylsulfonyl
chloride (81 µL, 1.04 mmol, 1.2 equiv).
The ice-bath was removed and the solution was stirred at r.t. for 15 min.
Sat. NaHCO3 (5 mL) was added and the layers
were separated. The organic layer was washed with brine (2 × 5 mL)
and the combined aqueous layer was back-extracted with CH2Cl2 (2 × 10 mL).
The combined organic layer was dried over MgSO4, the
solids filtered off and the solvent removed in vacuo. The crude
product was purified by column chromatography (silica; PE-EtOAc,
7:3) to give a colourless solid (312 mg, 0.81 mmol,
93%); mp 61-63 C (CHCl3); [α]D
²8 -37.1
(c 0.11, CHCl3); IR: 3009,
1711, 1500, 1364, 1175 cm-¹; ¹H
NMR (400 MHz, CDCl3): δ = 1.39 (s, 9 H, tBu), 2.08 (m, 1 H, Hβ
1),
2.29 (m, 1 H, Hβ
2), 2.92
(s, 3 H, SO2CH3), 4.24 (m, 2 H,
Hγ), 4.43 (m, 1 H, Hα),
5.15 (s, 2 H, CH
2Ph),
5.26 (bd, J = 7.0 Hz, 1 H,
NH), 7.33 (m, 5 H, Ar); ¹³C
NMR (100 MHz, CDCl3): δ = 28.2 [C(CH3)3],
31.8 (Cβ), 37.1 (SO2CH3),
50.4 (Cα), 65.8 (Cγ), 67.5
(CH2Ph), 80.3 [C(CH3)3],
128.4, 128.5, 128.7, 135.0 (Ar), 155.3 (t
-BuOCONHR),
177.5 (CO2Bn); MS (ESI+): m/z [M + Na]+ calcd
for C17H25NNaO7S: 410.1244; found:
410.1225.
20 To a solution of mesylate 6 (222 mg, 0.56 mmol,
1.0 equiv) in anhydrous DMF (2 mL), was added
NaN3 (54 mg, 0.84 mmol, 1.5 equiv)
in one portion. The suspension was stirred at 40 ˚C
for 4 h, then the solvent was removed in vacuo and the
crude product was purified by column chromatography (silica; PE-EtOAc,
4:1). The azide 7 was obtained as a colourless
oil (171 mg, 0.51 mmol, 92%); [α]D
²8 +2.8
(c 0.71, CHCl3); IR: 3434,
2981, 2104, 1712, 1499, 1160 cm-¹; ¹H
NMR (400 MHz, CDCl3): δ = 1.41 (s, 9 H, tBu), 1.89 (m, 1 H, Hβ
1),
2.08 (m, 1 H, Hβ
2), 3.34
(t, J = 6.7 Hz, 2 H,
Hγ), 4.41 (m, 1 H, Hα),
5.13 (d, J = 12.3 Hz, 1 H, CH
2Ph), 5.18 (d, J = 12.3 Hz, 1 H, CH
2Ph), 5.19 (br s, 1 H, NH),
7.34 (m, 5 H, Ar); ¹³C NMR
(100 MHz, CDCl3): δ = 28.2 [C(CH3)3],
31.7 (Cβ), 47.6 (Cγ), 51.5
(Cα), 67.3 (CH2Ph),
80.2 [C(CH3)3],
128.3, 128.5, 128.6, 135.1 (Ar), 155.2 (tBuOCONHR), 171.8 (CO2Bn);
MS (ESI+): m/z [M + Na]+ calcd
for C16H22N4NaO4: 357.1533;
found: 357.1522.
21
Felix AM.
J.
Org. Chem.
1974,
39:
1427
22 To a solution of protected amino acid 7 (33 mg, 0.1 mmol, 1 equiv)
dissolved in anhydrous CH2Cl2 (2.5 mL)
at -10 ˚C under an N2 atmosphere,
boron tribromide solution (1 M in CH2Cl2,
0.5 mL, 0.5 mmol, 5 equiv) was added
dropwise over 5 min. The resulting solution was stirred for 1 h
at
-10 ˚C and for 2 h
at r.t. The reaction was quenched by careful addition of H2O
(2.5 mL), and then the layers were separated. The organic
phase was washed with H2O (3 × 5 mL)
and the combined aqueous layer was evaporated to dryness. The crude
product was re-dissolved in a minimum amount of ethanol and the
pure product 2 was obtained by precipitation
at 4 ˚C as a colourless crystalline solid (14 mg, 0.1 mmol,
quantitative yield).